Richard A. Flavell | |
---|---|
Born | August 23, 1945 |
Alma mater | |
Awards | Colworth Medal (1980) William B. Coley Award (2012) |
Scientific career | |
Institutions |
Richard Anthony Flavell (born 23 August 1945 in Chelmsford, Essex) is an English molecular biologist, and Sterling Professor of Immunobiology, at Yale School of Medicine where he uses transgenic and gene-targeted mice to study Innate and Adaptive immunity, T cell tolerance and activation in immunity and autoimmunity, apoptosis, and regulation of T cell differentiation. [1] He is an investigator at the Howard Hughes Medical Institute. [2] In 2013, Flavell received the Vilcek Prize in Biomedical Science. [3] In July 2016, Flavell received an honorary doctorate degree from the University of Hull. [4] He is an honorary member of the British Society for Immunology. [5]
He earned a Ph.D. from University of Hull in 1970. He studied at the University of Amsterdam, and the University of Zurich, where he studied with Charles Weissmann. He taught at University of Amsterdam from 1974 to 1979, then headed the Laboratory of Gene Structure and Expression at the National Institute for Medical Research, Mill Hill, London from 1979 to 1982. Following a move to Biogen in 1982, he became the President and Chief Scientific Officer of Biogen until 1988, when he moved to Yale. [6]
Niels Kaj Jerne, FRS was a Danish immunologist. He shared the Nobel Prize in Physiology or Medicine in 1984 with Georges J. F. Köhler and César Milstein "for theories concerning the specificity in development and control of the immune system and the discovery of the principle for production of monoclonal antibodies".
Rolf Martin Zinkernagel AC is a professor of experimental immunology at the University of Zurich. Along with Peter C. Doherty, he shared the 1996 Nobel Prize in Physiology or Medicine for the discovery of how the immune system recognizes virus-infected cells.
Jan T. Vilček is a Slovak-American biomedical scientist, educator, inventor and philanthropist. He is a professor in the department of microbiology at the New York University School of Medicine, and chairman and CEO of The Vilcek Foundation. Vilček received his M.D. degree from Comenius University Medical School in Bratislava in 1957; and his Ph.D. in Virology from the Institute of Virology, Czechoslovak Academy of Sciences, Bratislava, in 1962.
Sankar Ghosh is an Indian-American immunologist, microbiologist, and biochemist, who is the Chair and Silverstein & Hutt Family Professor of the Department of Microbiology & Immunology at Columbia University Irving Medical Center. Ghosh is best known for his pioneering research on the activation of cellular responses via NF-κB, a transcription factor that plays a critical role in regulating the expression of a large number of genes involved in the mammalian immune system. Ghosh's research led to the first cloning and characterization of NF-κB and IkB proteins, including the demonstration of the role of IkB phosphorylation in the activation of NF-κB.
The Max Planck Institute of Immunobiology and Epigenetics in Freiburg, Germany is an interdisciplinary research institute that conducts basic research in modern immunobiology, developmental biology and epigenetics. It was founded in 1961 as the Max Planck Institute of Immunobiology and is one of 86 institutions of the Max Planck Society. Originally named the Max Planck Institute of Immunobiology, it was renamed to its current name in 2010 as it widened its research thrusts to the study of epigenetics.
Charles Alderson Janeway, Jr. (1943–2003) was an American immunologist who helped create the modern field of innate immunity. A member of the National Academy of Sciences, he held a faculty position at Yale University's Medical School and was an Howard Hughes Medical Institute Investigator.
Philippa "Pippa" Marrack, FRS is an English immunologist and academic, based in the United States, best known for her research and discoveries pertaining to T cells. Marrack is the Ida and Cecil Green Professor and chair of the Department of Biomedical Research at National Jewish Health and a distinguished professor of immunology and microbiology at the University of Colorado Denver.
Franklin Gerardus "Frank" Grosveld, FRS is a Dutch molecular biologist whose research interests are in the regulation of transcription during development with a particular emphasis on mammalian erythroid differentiation. He is a professor and former Head of the Department of Cell Biology at the Erasmus MC, Rotterdam.
Joan Massagué, is a Spanish biologist and the current director of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is also an internationally recognized leader in the study of both cancer metastasis and growth factors that regulate cell behavior, as well as a professor at the Weill Cornell Graduate School of Medical Sciences.
Ruslan Maksutovich Medzhitov is a professor of immunobiology and dermatology at the Yale School of Medicine, and an investigator at the Howard Hughes Medical Institute. His research focuses on the analysis of the innate immune system, inflammatory response, innate control of the adaptive immunity, and host-pathogen interactions. In 2010, he was elected to the National Academy of Sciences, and in 2017 he was named Sterling Professor.
Peter Cresswell FRS is a British immunologist, and Eugene Higgins Professor of Immunobiology and Professor of Cell Biology and of Dermatology, at Yale School of Medicine. His lab primary focuses on the molecular mechanisms of antigen processing particularly the functions of the major histocompatibility complex (MHC) molecules and CD1 molecules. He is most notable for discovering and identifying the MHC class II molecules and viperin.
James Patrick Allison is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center in Houston, Texas. Allison is Regental Professor and Founding-Director of James P. Allison Institute at the MD Anderson Cancer Center.
Andrew D. Luster is the Persis, Cyrus and Marlow B. Harrison Professor of Medicine at Harvard Medical School, and the Chief of the Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital. He is Director of its Research Center for Immunology and Inflammatory Diseases, and a member of the Dana-Farber/Harvard Cancer Center's Cancer Immunology program.
Titia de Lange is the Director of the Anderson Center for Cancer Research, the Leon Hess professor and the head of Laboratory Cell Biology and Genetics at Rockefeller University.
Helen Kim Bottomly is an American immunologist and the former president of Wellesley College, serving from August 2007 to July 2016. Bottomly was the first scientist to become a president at Wellesley College. She has been a member of the American Academy of Arts and Sciences since 2009. She chaired the board of directors of the Consortium on Financing Higher Education and was a member of the advisory council of the National Institutes of Allergy and Infectious Diseases at the National Institutes of Health. In May 2018, she was appointed as the chair of the board of the trustees for the Fulbright University Vietnam, which she stepped down from in 2019.
Akiko Iwasaki is a Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University. She is also a principal investigator at the Howard Hughes Medical Institute. Her research interests include innate immunity, autophagy, inflammasomes, sexually transmitted infections, herpes simplex virus, human papillomavirus, respiratory virus infections, influenza infection, T cell immunity, commensal bacteria, COVID-19, and long COVID.
Adrian Clive Hayday is a British immunologist who is the Kay Glendinning professor and chair in the Department of Immunobiology at King's College London and group leader at the Francis Crick Institute in the UK.
Ibrahim I. Cissé is a Nigerien-American biophysicist. He is currently director of the Max Planck Institute of Immunobiology and Epigenetics. Previously, Cissé was at the California Institute of Technology as Professor of Physics and the Massachusetts Institute of Technology as Professor of Physics and Biology. He has won several awards for his work, including in 2021 the MacArthur Fellowship.
Carla V. Rothlin is an Argentinian immunologist. She is a professor of immunobiology at Yale University, where she holds the Dorys McConnell Duberg Professorship, and also serves as a professor of pharmacology. Rothlin is the co-leader of the Cancer Immunology Program at Yale Cancer Center and a Howard Hughes Medical Investigator Faculty Scholar.
Tim Harris is a molecular biologist/biochemist who is a science and business leader who has led laboratory work, scientists and companies in a range of research activities in the Biotechnology Industry since 1978.